| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |